CDNA – CareDx, Inc

CDNA — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

14.28

Margin Of Safety %

-19

Put/Call OI Ratio

0.22

EPS Next Q Diff

0.25

EPS Last/This Y

1.09

EPS This/Next Y

0.4

Price

17.69

Target Price

25.17

Analyst Recom

2.11

Performance Q

-10.8

Upside

-177.2%

Beta

2.52

Ticker: CDNA

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	CDNA	17.74	0.40	0.00	404
2026-03-10	CDNA	17	0.40	0.00	404
2026-03-11	CDNA	17.14	0.40	999.99	402
2026-03-12	CDNA	16.47	0.40	0.00	403
2026-03-13	CDNA	16.45	0.40	0.00	403
2026-03-17	CDNA	17.61	0.40	999.99	408
2026-03-18	CDNA	17.37	0.40	1.00	408
2026-03-19	CDNA	17.57	0.42	0.00	428
2026-03-20	CDNA	17.18	0.40	0.00	439
2026-03-23	CDNA	17.55	0.35	0.33	337
2026-03-24	CDNA	17.83	0.22	6.00	379
2026-03-25	CDNA	18.1	0.24	0.00	386
2026-03-26	CDNA	17.47	0.24	0.00	386
2026-03-27	CDNA	16.77	0.24	0.00	386
2026-03-30	CDNA	16.41	0.24	0.00	386
2026-03-31	CDNA	17.37	0.23	0.00	407
2026-04-01	CDNA	17.86	0.23	0.00	408
2026-04-02	CDNA	18.31	0.22	0.00	410
2026-04-06	CDNA	17.82	0.22	0.00	411
2026-04-07	CDNA	17.68	0.22	0.00	411
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	CDNA	17.71	31.7	-	0.69
2026-03-10	CDNA	17.00	31.7	-	0.69
2026-03-11	CDNA	17.13	31.7	-	0.69
2026-03-12	CDNA	16.44	31.7	-	0.69
2026-03-13	CDNA	17.02	31.7	-	0.69
2026-03-17	CDNA	17.62	31.7	-	0.69
2026-03-18	CDNA	17.36	31.7	-	0.69
2026-03-19	CDNA	17.58	31.7	-	0.69
2026-03-20	CDNA	17.16	31.7	-	0.69
2026-03-23	CDNA	17.55	31.7	-	0.69
2026-03-24	CDNA	17.83	31.7	-	0.69
2026-03-25	CDNA	18.08	31.7	-	0.69
2026-03-26	CDNA	17.46	31.7	-	0.69
2026-03-27	CDNA	16.77	31.7	-	0.69
2026-03-30	CDNA	16.42	31.7	-	0.69
2026-03-31	CDNA	17.36	31.7	-	0.69
2026-04-01	CDNA	17.85	31.7	-	0.69
2026-04-02	CDNA	18.30	31.7	-	0.69
2026-04-06	CDNA	17.82	31.7	-	0.69
2026-04-07	CDNA	17.69	31.7	-	0.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	CDNA	-0.78	-0.70	13.33
2026-03-10	CDNA	-0.78	-0.70	13.33
2026-03-11	CDNA	-0.78	-0.70	13.75
2026-03-12	CDNA	-0.78	-0.70	13.75
2026-03-13	CDNA	-0.78	-0.70	13.75
2026-03-17	CDNA	-0.78	-0.67	13.75
2026-03-18	CDNA	-0.78	-0.67	13.75
2026-03-19	CDNA	-0.78	-0.67	13.75
2026-03-20	CDNA	-0.78	-0.67	13.75
2026-03-23	CDNA	-0.78	-0.66	13.75
2026-03-24	CDNA	-0.78	-0.66	13.75
2026-03-25	CDNA	-0.78	-0.66	14.28
2026-03-26	CDNA	-0.78	-0.66	14.28
2026-03-27	CDNA	-0.78	-0.66	14.28
2026-03-30	CDNA	-0.78	-0.66	14.28
2026-03-31	CDNA	-0.78	-0.66	14.28
2026-04-01	CDNA	-0.78	-0.66	14.28
2026-04-02	CDNA	-0.78	-0.66	14.28
2026-04-06	CDNA	-0.78	-0.70	14.28
2026-04-07	CDNA	-0.78	-0.70	14.28
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.08

Avg. EPS Est. Current Quarter

0.13

Avg. EPS Est. Next Quarter

0.17

Insider Transactions

-0.78

Institutional Transactions

-0.7

Beta

2.52

Average Sales Estimate Current Quarter

102

Average Sales Estimate Next Quarter

106

Fair Value

14.29

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

81.7

Max Drawdown 5-Year %

-94.8

Target Price

25.17

P/E

Forward P/E

62.22

PEG

P/S

2.38

P/B

2.97

P/Free Cash Flow

25.06

EPS

-0.39

Average EPS Est. Cur. Y

0.69

EPS Next Y. (Est.)

1.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-5.62

Relative Volume

0.73

Return on Equity vs Sector %

-34.5

Return on Equity vs Industry %

-17.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.2

EBIT Estimation

◆ CDNA Healthcare

$17.67

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

15/25

Volume

9/15

Valuation

15/20

TP/AR

3/10

Options

7/10

RSI

48.5

Range 1M

50.9%

Sup Dist

0.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

19/30

Estimates

4/20

Inst/Vol

0/15

Options

8/10

EPS Yr

82.9%

EPS NY

515.6%

52W%

63.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +60.7% upside

Quality

7/30

Valuation

18/30

Growth

15/25

Stability

8/10

LT Trend

1/5

Upside

+60.7%

Quality

MoS

-19%

CareDx, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 761

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. It also offers HeartCare, which provides information about distinct biological processes, such as immune quiescence, active injury, acute cellular rejection, and antibody mediated rejection; HistoMap Kidney, a solution that identifies allograft rejection and type of rejection in kidney transplant biopsy tissue; and AlloHeme, a monitoring test that predicts relapse in patients with acute myeloid leukemia and myelodysplastic syndromes. In addition, the company provides QTYPE that enables precision in human leukocyte antigen (HLA) typing; Olerup SSP, which is used to type HLA alleles based on sequence specific primer technology; and Ottr, a transplant patient management software. Further, it offers AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a solution that monitors the pharmacokinetics of engraftment and persistence of cells for patients who have received allogeneic cell therapy; and XynQAPI, MedActionPlan, CareDx pharmacy, AlloHome, and HLA Data Systems software solutions. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in Brisbane, California.

CDNA

Latest News

—

Caricamento notizie per CDNA…

stock quote shares CDNA – CareDx, Inc Stock Price stock today

news today CDNA – CareDx, Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch CDNA – CareDx, Inc yahoo finance google finance

stock history CDNA – CareDx, Inc invest stock market

stock prices CDNA premarket after hours

ticker CDNA fair value insiders trading

CDNA – CareDx, Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CDNA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y